miR-22 suppresses cell viability and EMT of ovarian cancer cells via NLRP3 and inhibits PI3K/AKT signaling pathway

被引：0
作者：
H. Wu
J. Liu
Y. Zhang
Q. Li
Q. Wang
Z. Gu
机构：
[1] Jining No.1 People’s Hospital,Department of Gynaecology
[2] The Third People’s Hospital of Qingdao,Department of Obstetrics
[3] Qingdao Central Hospital,Education Management Section
[4] Qingdao University,Department of Clinical Laboratory
[5] The People’s Hospital of Zhangqiu Area,No.2 Department of Otorhinolaryngology
[6] The People’s Hospital of Zhangqiu Area,Department of Obstetrics and Gynecology
[7] The 5th People’s Hospital of Ji’nan,undefined
来源：
Clinical and Translational Oncology | 2021年 / 23卷
关键词：
miR-22; Viability; EMT; PI3K/AKT; Ovarian cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：257 / 264
页数：7
相关论文
共 54 条
[1]  
Slack FJ(2008)MicroRNA in cancer prognosis N Engl J Med 359 2720-2722
[2]  
Weidhaas JB(2011)Stressed tumor cell, chemosensitized cancer Nat Med 17 1552-1554
[3]  
Wiemer EA(2017)Ovarian cancer epidemiology in the era of collaborative team science Cancer Causes Control 28 487-495
[4]  
Cannioto RA(2018)Cancer statistics, 2018 CA Cancer J Clin 68 7-30
[5]  
Trabert B(2007)miRNAs get an early start on translational silencing Cell 131 25-28
[6]  
Poole EM(2009)MicroRNAs in cancer Annu Rev Pathol 4 199-227
[7]  
Siegel RL(2019)HypoxamiRs Profiling Identify miR-745 as a regulator of the early stages of vasculogenic mimicry in SKOV3 ovarian cancer cells Front Oncol 9 381-3305
[8]  
Miller KD(2019)miR-450a acts as a tumor suppressor in ovarian cancer by regulating energy metabolism Cancer Res 79 3294-57
[9]  
Jemal A(2019)miR-590-3p targets cyclin G2 and FOXO3 to promote ovarian cancer cell proliferation, invasion, and spheroid formation Int J Mol Sci 20 1810-293
[10]  
Meister G(2020)The promising signatures of circulating microRNA-145 in epithelial ovarian cancer patients Microrna. 9 49-5424
123456